Last update 01 Nov 2024
EnzymeRx LLC

EnzymeRx LLC

Private Company|
2008|
New Jersey, United States
|
< 10
|
www.enzymerx.com

Overview

Tags

Congenital Disorders
Immune System Diseases
Endocrinology and Metabolic Disease
Enzyme

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Enzyme1
Top 5 TargetCount
Uric acid1

Related

1
Drugs associated with EnzymeRx LLC
Pegadricase
Target
Uric acid
Mechanism
Uric acid stimulants
Active Org.
Shenyang Sunshine Pharmaceuticals Co., Ltd.Shenyang Sunshine Pharmaceuticals Co., Ltd. [+4]
Originator Org.
Polaris Inc.Polaris Inc.
Active Indication
Tumor Lysis Syndrome [+3]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with EnzymeRx LLC
NCT01038947 / Unknown statusPhase 1
A Cohort Dose-Escalation Phase 1 Study of Intramuscular Injection of Uricase-PEG 20
NCT01021241 / Unknown statusPhase 1
A Cohort Dose-Escalation Phase 1 Study of Intravenous Infusion of Uricase-PEG 20
100 Clinical Results associated with EnzymeRx LLC
Login to view more data
0 Patents (Medical) associated with EnzymeRx LLC
Login to view more data
100 Deals associated with EnzymeRx LLC
Login to view more data
100 Translational Medicine associated with EnzymeRx LLC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Pegadricase
 ( Uric acid )		Tumor Lysis Syndrome
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free